NOVONIX (NVX.AX) Stock Price
NOVONIX Price
Revenue has compounded at 66.3% per year over the past 10 years to 5.62 M USD. NOVONIX's net margin stands at -1,650.8%, down from -673.7% several years earlier.
NOVONIX stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
NOVONIX business model & stock analysis
Frequently asked questions about NOVONIX
5 analysts currently rate the NOVONIX stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect NOVONIX to generate revenue of 3.23 M USD and earnings per share of -0.01 USD.
Converted at the current exchange rate, the NOVONIX share trades at 0.05 EUR (0.06 USD).
The NOVONIX share (NVX.AX) is listed on 4 stock exchanges, including: ASX (NVX.AX), Frankfurt (GC3.F), Düsseldorf (GC3.DU).
The expected revenue of NOVONIX is 3.23 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of NOVONIX is -4.54 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of NOVONIX is currently -8.57. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the NOVONIX stock.
The price-to-sales ratio (P/S) of NOVONIX is currently 12.02. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the NOVONIX stock.
The Eulerpool Quality Score for NOVONIX is 6/10.
The ISIN of NOVONIX is AU000000NVX4. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of NOVONIX is A2DUU7. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of NOVONIX is NVX.AX. The ticker symbol is used to trade NOVONIX shares on the stock exchange.
NOVONIX stock
NOVONIX Peer Group
NOVONIX Ticker
NOVONIX FIGI
All fundamentals and in-depth analysis of NOVONIX
Our stock analysis for NOVONIX stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NOVONIX. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.